CSIMarket
 
Avid Bioservices Inc   (NASDAQ: CDMO)
 

Avid Bioservices Inc's Customers Performance

CDMO



 
CDMO's Source of Revenues During the corresponding time, Avid Bioservices Inc recorded a revenue increase by 32.16 % year on year, sequentially revenue fell by -16.66 %. While revenue at the Avid Bioservices Inc 's corporate clients

List of CDMO Customers




for the same period Avid Bioservices Inc recorded revenue increase by 32.16 % year on year, sequentially revenue fell by -16.66 %.

List of CDMO Customers

Avid Bioservices Inc's Business Units
Manufacturing Revenues    81.46 % of total Revenue
Process Development Revenues    18.54 % of total Revenue






Avid Bioservices Inc's Comment on Sales, Marketing and Customers



The company provides outsourced development and manufacturing services for biopharmaceuticals derived from mammalian cell culture. Its clients include pharmaceutical companies requiring biomanufacturing support from early preclinical stages through commercial launch and supply. The company specializes in complex molecules such as monoclonal antibodies, next-generation antibodies, and recombinant proteins. Its services encompass process development, CGMP drug substance biomanufacturing, project management, quality systems, and quality control. The company maintains a focus on regulatory compliance and has a history of successful inspections and approvals, including FDA pre-approval inspections.





Avid Bioservices Inc’s Comment on Sales, Marketing and Customers


The company provides outsourced development and manufacturing services for biopharmaceuticals derived from mammalian cell culture. Its clients include pharmaceutical companies requiring biomanufacturing support from early preclinical stages through commercial launch and supply. The company specializes in complex molecules such as monoclonal antibodies, next-generation antibodies, and recombinant proteins. Its services encompass process development, CGMP drug substance biomanufacturing, project management, quality systems, and quality control. The company maintains a focus on regulatory compliance and has a history of successful inspections and approvals, including FDA pre-approval inspections.








CDMO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Avid Bioservices Inc 797.34 150.54 -152.05 371
SUBTOTAL 0.00 0.00 0.00 -

Sources: Avid Bioservices Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Avid Bioservices Inc’s corporate clients.
For your research, we’ve provided 9 tables on Avid Bioservices Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.